CVS Health is a company in transition, moving away from the old pharmacy chain to an integrated healthcare giant. Read more ...

Stock Yards Bank & Trust Co. trimmed its CVS Health stake by 17.1% in Q1, selling 5,409 shares and retaining 26,239 shares ...

CVS Health (NYSE:CVS) snapped seven straight sessions of gains as the stock closed 0.92% lower, at $67.09 on Tuesday. The ...

CVS Health CVS has seen its stock surge by 53.7% in 2025, fueled by a potent combination of strong operational performance ...

Eli Lilly and Company (NYSE:LLY) may be affected by the CVS formulary change considering it could change how its medication, Zepbound, is viewed when compared to Wegovy. That said, despite possible ...

Ariel Investments, an investment management company, released its “Ariel Global Fund” first-quarter 2025 investor letter. A ...

CVS Health saw its stock get a financial boost as Fifth Third Bancorp increased its stake by 4.6% in Q1, bringing its holdings to 169,749 shares valued at $11.5 million. Other financial powerhouses ...

CVS Health's revenues have an average growth rate of 7.2% with operating expenses growing at 20.4%. The company's current ...

Shares of CVS Health Corp. CVS rose 1.67% to $67.46 Friday, on what proved to be an all-around poor trading session for the ...

After digesting Cardinal Health's 2025 investor day, we inched up our 2026 revenue and EPS assumptions and lifted our stage II growth rates by 50 basis points to reflect a stronger distribution market ...

It's just over a week since pharmacy benefit managers CVS and Express Scripts sued the state of Arkansas over a new monopoly-busting law prohibiting PBMs—middle ...

CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...